Process for the preparation of (3r,3as,6ar)-hexahydrofuro2,3-bfuran-3-yl(1s,2r)-3-(4-aminophenyl)sulfonyl(isobutyl)amino-1-benzyl-2-hydroxypropylcarbamate
CA2733762A1
Macrocyclic indole derivatives useful as hepatitis c virus inhibitors
UA103324C2
Normal;heading 1;heading 2;heading 3;MACROCYCLIC INDOLE DERIVATIVES USEFUL AS HEPATITIS C VIRUS INHIBITORS
TW201014865A
Macrocyclic indole derivatives useful as hepatitis c virus inhibitors
EP2306980A2
Powders for reconstitution
AU2009218462A1
Method for identifying inhibitors against viruses that use a class I fusion protein
AU2008339917A1
Macrocyclic indoles as hepatitis C virus inhibitors
AU2008333164A1
Method for determining one of the two Human Immunodeficiency Virus (HIV) integrase enzymatic activities
WO2009013352A1
Native gp41 assay
AU2008278974A1
Anti-HIV tablet formulations comprising darunavir
CA2693044A1
Crystalline form of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2 pyrimidinyl]amino]benzonitrile
CN101790371A
Comprise the combination preparation that reaches that Wei of reed and comply with bent Wei Lin
AU2008257703A1
New mutational profile in HIV-1 Gag cleavage site correlated with phenotypic drug resistance
CN101668734A
The preparation method of N-isobutyl--N-(2-hydroxyl-3-amino-4-phenyl butyl)-right-nitrobenzene sulfonamide derivative
